MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Research summaries

CORe Unit

MS Treatments Delay Progressive Disease

MStranslate
February 12, 2019
Progressive MS, Research, Treatments
Research Summary: Association of Initial Disease-Modifying With Later Conversion to Secondary Progressive Multiple Sclerosis In mid-January, we had...
food allergy

Food Allergies & Increased Disease Activity In MS

MStranslate
January 2, 2019
Basic Sciences, Diet, Lifestyle, Research
Recently, we featured a Facebook post that mentioned the results of two major US studies, including one that looked at the links between multiple...
asthma

Asthma More Common In People With MS

MStranslate
December 28, 2018
Basic Sciences, Research
1 Comment
Recently, we featured a Facebook post that mentioned the results of two major US studies, one of which looked at the links between multiple sclerosis...
smell

The Nose Knows: Can Smell Be A Marker Of MS Progression?

MStranslate
December 6, 2018
Research
Research Summary: Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or...
treatment decision

What influences the choice of treatment in MS?

MStranslate
November 28, 2018
Research, Treatments, Uncategorized
Research Summary: Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: A critical...
T Cell Therapy

EBV-Specific T Cell Therapy for Progressive MS

MStranslate
November 20, 2018
Epstein-Barr virus, Infection, Progressive MS, Research, Treatments
Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we...
ibudilast

Ibudilast Phase 2 Trial Results for Progressive MS

MStranslate
August 30, 2018
Progressive MS, Research, Treatments
Research Summary: Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis What is it? Ibudilast is an anti-inflammatory treatment, which also...
heart disease

Heart Disease Linked To Brain Atrophy In MS

MStranslate
August 15, 2018
Basic Sciences, Lifestyle, Research
2 Comments
Research Summary:  Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal...
primary progressive MS research

Primary Progressive MS Research: Treatment Outcomes

MStranslate
August 9, 2018
Progressive MS, Research, Treatments
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS Primary progressive multiple sclerosis (PPMS) is characterised by a steady worsening of disease or...
blood platelets

Inflammation in the CNS is driven by platelets

MStranslate
July 31, 2018
Basic Sciences, Ocular Motor, Research
1 Comment
RESEARCH SUMMARY:  Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis. In this article, we...
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.